Logo Logo

Publications by Prasse, A.

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 6.

Journal article

Kreuter, M.; Ochmann, U.; Koschel, D.; Behr, J.; Bonellas, F.; Claussen, M.; Costabels, U.; Jungmann, S.; Kolb, M.; Nowak, D.; Petermann, F.; Pfeiffer, M.; Polke, M.; Prasse, A.; Schreiber, J.; Waelscher, J.; Wirtz, H.; Kirsten, D. (2018): Patientenfragebogen zur Erfassung der Ursachen interstitieller und seltener Lungenerkrankungen – klinische Sektion der DGP. In: Pneumologie, Vol. 72, No. 6: pp. 446-457

Behr, J.; Günther, A.; Kreuter, M.; Koschel, D.; Prasse, A.; Pfeifer, M.; Costabel, U. (2017): Erfahrungen und unterstützende Hinweise zur Anwendung von Nintedanib bei Patienten mit idiopathischer Lungenfibrose. In: Pneumologie, Vol. 71, No. 9: pp. 567-579

Jarosch, I.; Schneeberger, T.; Gloeckl, R.; Kreuter, M.; Benstz, J.; Frankenberger, M.; Neurohr, C.; Prasse, A.; Behr, J.; Kenn, K. (2017): Different Effects Of Pulmonary Rehabilitation In Anxious Vs. Non-Anxious Patients With Idiopathic Pulmonary Fibrosis - A Pilot Study. In: American Journal of Respiratory and Critical Care Medicine, Vol. 195

Kreuter, M.; Swigris, J. J.; Pittrow, D.; Prasse, A.; Klotsche, J.; Geier, S.; Wirtz, H.; Koschel, D.; Andreas, S.; Grohe, C.; Claussen, M.; Behr, J. (2017): Quality Of Life (qol) Trajectory In Patients With Idiopathic Pulmonary Fibrosis (ipf): Longitudinal Qol Assessment Of The Insights-Ipf Registry. In: American Journal of Respiratory and Critical Care Medicine, Vol. 195

Behr, J.; Wirtz, H.; Prasse, A.; Pittrow, D.; Klotsche, J.; Koschel, D.; Andreas, S.; Claussen, M.; Grohe, C.; Kreuter, M. (2016): Predictors Of Mortality In Patients With Idiopathic Pulmonary Fibrosis Under Clinical Practice Conditions: Insights-Ipf Registry. In: American Journal of Respiratory and Critical Care Medicine, Vol. 193

Bonella, F.; Kreuter, M.; Hagmeyer, L.; Neurohr, C.; Keller, C.; Kohlhaeufl, M.; Mueller-Quernheim, J.; Milger, K.; Prasse, A. (2016): Insights From A Multi-Centre Real Life Experience In Germany With Nintedanib For The Treatment Of Idiopathic Pulmonary Fibrosis. In: American Journal of Respiratory and Critical Care Medicine, Vol. 193

This list was generated on Wed Sep 18 07:31:14 2019 CEST.